Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast Cancer”
Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
ClinicalTrials.gov study NCT04033419. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT03822468. IPD Sharing: YES. Countries: 23. Publications: 1.
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
ClinicalTrials.gov study NCT00263588. IPD Sharing: UNDECIDED. Countries: 17. Publications: 1.
NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer
ClinicalTrials.gov study NCT01816594. IPD Sharing: YES. Countries: 4. Publications: 1.
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00667251. IPD Sharing: YES. Countries: 21. Publications: 3.
RCT of CBD for Anxiety in Advanced Breast Cancer
ClinicalTrials.gov study NCT04482244. IPD Sharing: YES. Countries: 1. Publications: 1.
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00820222. IPD Sharing: UNDECIDED. Countries: 14. Publications: 1.
A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
ClinicalTrials.gov study NCT03248492. IPD Sharing: YES. Countries: 9. Publications: 6.
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.
ClinicalTrials.gov study NCT02437318. IPD Sharing: YES. Countries: 31. Publications: 6.
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
ClinicalTrials.gov study NCT03523585. IPD Sharing: YES. Countries: 15. Publications: 2.
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
ClinicalTrials.gov study NCT02400476. IPD Sharing: YES. Countries: 7. Publications: 2.
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-s
ClinicalTrials.gov study NCT03312738. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
ClinicalTrials.gov study NCT02422615. IPD Sharing: YES. Countries: 30. Publications: 10.
Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)
ClinicalTrials.gov study NCT05011279. IPD Sharing: YES. Countries: 1. Publications: 1.
Alcohol and Breast Cancer (ABC) Trial
ClinicalTrials.gov study NCT05423730. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibito
ClinicalTrials.gov study NCT01610284. IPD Sharing: YES. Countries: 29. Publications: 2.
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer
ClinicalTrials.gov study NCT03078751. IPD Sharing: YES. Countries: 1. Publications: 1.
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00073528. IPD Sharing: YES. Countries: 29. Publications: 6.
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
ClinicalTrials.gov study NCT02278120. IPD Sharing: YES. Countries: 30. Publications: 10.
Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.
ClinicalTrials.gov study NCT03273426. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.